International law firm Freshfields Bruckhaus Deringer has advised the international healthcare group Fresenius SE & Co. KGaA on the successful placement of senior unsecured notes in a principal amount of €500 million.
The senior notes were issued by Fresenius Finance B.V., a wholly owned subsidiary of Fresenius SE & Co. KGaA, and offered through a private placement to institutional investors.
The senior notes have a coupon of 4.250% and a maturity of seven years. The transaction was well received by investors and substantially oversubscribed.
Freshfields had previously advised Fresenius on the increase of a bond issued in 2006 by a nominal €150 million in 2009 and the successful pricing and closing of its dual tranche $860 million equivalent offering of senior notes, which proceeds were used for the acquisition of APP Pharmaceuticals.
The Freshfields team comprised corporate and capital markets partners Andreas König and Mark Strauch as well as capital markets associates Timothy Knauff, Kyle Miller and Julian Schulze de la Cruz in Frankfurt.
(Press Release by Freshfields Bruckhaus Deringer)
